SEARCH

SEARCH BY CITATION

References

  • Barnes DA, Foote SJ, Galatis D, Kemp DJ & Cowman AF (1992) Selection for high-level chloroquine resistance results in deamplification of the pfmdr1 gene and increased sensitivity to mefloquine in Plasmodium falciparum. The EMBO Journal 11, 30673075.
  • Basco LK, Le Bras J, Rhoades Z & Wilson CM (1995) Analysis of pfmdr1 and drug susceptibility in fresh isolates of Plasmodium falciparum from subsaharan Africa. Molecular and Biochemical Parasitology 74, 157166.
  • Chaiyaroj SC, Buranakiti A, Angkasekwinai P, Looressuwan S & Cowman AF (1999) Analysis of mefloquine resistance and amplification of pfmdr1 in multidrug-resistant Plasmodium falciparum isolates from Thailand. The American Journal of Tropical Medicine and Hygiene 61, 780783.
  • Cowman AF, Galatis D & Thompson JK (1994) Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine. Proceedings of the National Academy of Sciences of the United States of America 91, 11431147.
  • Dokomajilar C, Nsobya SL, Greenhouse B, Rosenthal PJ & Dorsey G (2006) Selection of Plasmodium falciparum pfmdr1 Alleles following Therapy with Artemether-Lumefantrine in an Area of Uganda where Malaria Is Highly Endemic. Antimicrobial Agents and Chemotherapy 50, 18931895.
  • Duraisingh MT & Cowman AF (2005) Contribution of the pfmdr1 gene to antimalarial drug-resistance. Acta Tropica 94, 181190.
  • Duraisingh MT, Roper C, Walliker D & Warhurst DC (2000) Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum. Molecular Microbiology 36, 955961.
  • Hassan Alin M, Bjorkman A & Wernsdorfer WH (1999) Synergism of benflumetol and artemether in Plasmodium falciparum. The American Journal of Tropical Medicine and Hygiene 61, 439445.
  • Hastings IM & Ward SA (2005) Coartem (artemether-lumefantrine) in Africa: the beginning of the end? The Journal of Infectious Diseases 192, 13031304; author reply 1304–1305.
  • Holmgren G, Bjorkman A & Gil JP (2006) Amodiaquine resistance is not related to rare findings of pfmdr1 gene amplifications in Kenya. Tropical Medicine and International Health 11, 18081812.
  • Jambou R, Legrand E, Niang M et al. (2005) Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet 366, 19601963.
  • Johnson DJ, Fidock DA, Mungthin M et al. (2004) Evidence for a central role for PfCRT in conferring Plasmodium falciparum resistance to diverse antimalarial agents. Molecular Cell 15, 867877.
  • Krishna S, Woodrow CJ, Staines HM, Haynes RK & Mercereau-Puijalon O (2006) Re-evaluation of how artemisinins work in light of emerging evidence of in vitro resistance. Trends in Molecular Medicine 6, 6.
  • Martensson A, Stromberg J, Sisowath C et al. (2005) Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 41, 10791086. Epub 2005 September 1013.
  • Mugittu K, Adjuik M, Snounou G et al. (2006) Molecular genotyping to distinguish between recrudescents and new infections in treatment trials of Plasmodium falciparum malaria conducted in Sub-Saharan Africa: adjustment of parasitological outcomes and assessment of genotyping effectiveness. Tropical Medicine and International Health 11, 13501359.
  • Price RN, Uhlemann AC, Brockman A et al. (2004) Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 364, 438447.
  • Price RN, Uhlemann AC, Vugt MV et al. (2006) Molecular and Pharmacological Determinants of the Therapeutic Response to Artemether-Lumefantrine in Multidrug-Resistant Plasmodium falciparum Malaria. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 42, 15701577. Epub 2006 April 1526.
  • Ritchie GY, Mungthin M, Green JE, Bray PG, Hawley SR & Ward SA (1996) In vitro selection of halofantrine resistance in Plasmodium falciparum is not associated with increased expression of Pgh1. Molecular and Biochemical Parasitology 83, 3546.
  • Sisowath C, Stromberg J, Martensson A et al. (2005) In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). The Journal of Infectious Diseases 191, 10141017 Epub 2005 February 1018.
  • Snounou G, Zhu X, Siripoon N et al. (1999) Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Transactions of the Royal Society of Tropical Medicine and Hygiene 93, 369374.
  • Uhlemann AC, Ramharter M, Lell B, Kremsner PG & Krishna S (2005) Amplification of Plasmodium falciparum multidrug resistance gene 1 in isolates from Gabon. The Journal of Infectious Diseases 192, 18301835 Epub 2005 October 1837.
  • Woodrow CJ & Krishna S (2006) Antimalarial drugs: recent advances in molecular determinants of resistance and their clinical significance. Cellular and Molecular Life Sciences 15, 15.